|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
TNG Pharmaceuticals Hires Serge Martinod as CEO
2/14/2013 8:37:15 AM
Louisville-based TNG Pharmaceuticals Inc. has hired Serge Martinod as its CEO and chief science officer. Martinod has extensive experience developing animal pharmaceuticals and has led two startup, venture-capital-funded companies, including Arcanatura LLC. “He’s a scientist who’s not afraid to get his hands dirty,” said Jenny Corbin, a co-founder of TNG, in an interview. The company is developing a vaccine, FlyVax, which immunizes cattle against the horn fly, a pest that Corbin said costs the beef cattle and dairy industry an estimated $1 billion in lost production annually. “This technology has the potential to make a significant difference in animal health,” Martinod said in a news release. TNG was founded 18 months ago by Corbin and other University of Louisville MBA students as a class project. Since then, the company has won $475,000 in cash or convertible notes in business plan competitions across the country.
|
|
|
|
|
|
|
|
|
|
|